Orchestra BioMed Holdings, Inc. (OBIO)
NASDAQ: OBIO · Real-Time Price · USD
0.00
-0.0300 (-0.77%)
Apr 29, 2026, 9:38 AM EDT - Market open
Orchestra BioMed Holdings Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2020 |
| Net Income | -52.7 | -61.02 | -49.12 | -33.61 | -23.01 | Upgrade
|
| Depreciation & Amortization | 0.33 | 0.31 | 0.29 | 0.22 | 0.18 | Upgrade
|
| Other Amortization | 0.22 | 0.03 | 0.11 | 0.16 | 0.22 | Upgrade
|
| Asset Writedown & Restructuring Costs | - | 1.05 | - | - | - | Upgrade
|
| Loss (Gain) From Sale of Investments | -0.81 | -1.43 | -3.8 | -1.63 | 0.29 | Upgrade
|
| Stock-Based Compensation | 11.98 | 10.62 | 7.63 | 3.41 | 0.3 | Upgrade
|
| Other Operating Activities | 2.4 | 0.67 | 2.08 | 2.6 | -0.03 | Upgrade
|
| Change in Accounts Receivable | -0 | 0.02 | -0 | 0.03 | 0.05 | Upgrade
|
| Change in Inventory | -0.14 | -0.03 | 0.13 | -0.21 | 0 | Upgrade
|
| Change in Accounts Payable | 4.87 | 2.97 | 0.15 | 3.35 | 1.08 | Upgrade
|
| Change in Unearned Revenue | -15.43 | -2.01 | -2.11 | -2.86 | 1.48 | Upgrade
|
| Change in Other Net Operating Assets | 0.33 | -1.72 | -1.47 | -0.76 | 0.03 | Upgrade
|
| Operating Cash Flow | -48.96 | -50.56 | -46.13 | -29.29 | -19.43 | Upgrade
|
| Capital Expenditures | -0.49 | -0.29 | -0.08 | -0.59 | -0.27 | Upgrade
|
| Cash Acquisitions | - | -0.6 | - | - | - | Upgrade
|
| Investment in Securities | -26.45 | 13.98 | 10.77 | -63.53 | 13.5 | Upgrade
|
| Other Investing Activities | - | - | - | - | -0.21 | Upgrade
|
| Investing Cash Flow | -26.94 | 13.09 | 10.69 | -64.12 | 13.02 | Upgrade
|
| Long-Term Debt Issued | 20 | 15 | - | 10 | - | Upgrade
|
| Long-Term Debt Repaid | - | - | -10.85 | -6.45 | -4 | Upgrade
|
| Net Debt Issued (Repaid) | 20 | 15 | -10.85 | 3.55 | -4 | Upgrade
|
| Issuance of Common Stock | 59.41 | 15.28 | 0.25 | 0.2 | 0.01 | Upgrade
|
| Repurchase of Common Stock | -1.55 | -0.55 | - | - | - | Upgrade
|
| Other Financing Activities | -2.09 | -0.55 | 56.81 | -10.33 | - | Upgrade
|
| Financing Cash Flow | 88.33 | 29.17 | 46.22 | 103.26 | -3.99 | Upgrade
|
| Net Cash Flow | 12.43 | -8.3 | 10.78 | 9.85 | -10.41 | Upgrade
|
| Free Cash Flow | -49.45 | -50.85 | -46.21 | -29.88 | -19.7 | Upgrade
|
| Free Cash Flow Margin | -147.70% | -1927.48% | -1674.09% | -845.74% | - | Upgrade
|
| Free Cash Flow Per Share | -1.04 | -1.38 | -1.39 | -1.99 | -9.33 | Upgrade
|
| Cash Interest Paid | 1.45 | 0.1 | 1.12 | 1.37 | 0.39 | Upgrade
|
| Levered Free Cash Flow | -20.25 | -25.45 | -33.04 | -10.06 | -13.86 | Upgrade
|
| Unlevered Free Cash Flow | -19.28 | -25.3 | -32.28 | -10.22 | -13.5 | Upgrade
|
| Change in Working Capital | -10.37 | -0.77 | -3.31 | -0.45 | 2.63 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.